Hello, Fool! | Login | Signup | My Fool
Oct 12, 2008 8:54 PM ET | Feedback | Site Changes | Help
A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.
View All Commentary (ONXX)
Recs
withoutlimits (87.56) Submitted: 12/12/07 3:10 PM : Start Price: $55.53 ONXX Score: 8.56
I think it has exceed a reasonable price in the short term.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK